**Question:** All of the following are true regarding progressive multifocal leukoencephalopathy except

A. Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system caused by JC virus infection.
B. PML predominantly affects immunocompetent individuals.
C. PML presents with a rapidly progressive neurological decline.
D. PML is a common complication of solid organ transplantation.

**Correct Answer:** A. PML predominantly affects immunocompetent individuals.

**Core Concept:** Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system caused by JC virus infection. PML primarily affects individuals with a weakened immune system, such as those with acquired immune deficiency syndrome (AIDS) or undergoing immunosuppressive therapy. In such cases, the immune system fails to control the replication of the JC virus, allowing it to infect and damage the white matter of the brain.

**Why the Correct Answer is Right:** PML predominantly affects immunocompetent individuals because it requires a compromised immune system for the virus to cause significant damage to the central nervous system. In immunocompetent individuals, the immune system can effectively control the replication of the JC virus, preventing the disease.

**Why Each Wrong Option is Incorrect:**

B. False: PML predominantly affects immunocompetent individuals, not immunocompetent ones. Immunocompetent individuals have a robust immune system capable of controlling the virus, preventing the disease.
C. False: PML presents with a slowly progressive neurological decline in most cases, not a rapidly progressive one. The disease typically evolves over weeks to months rather than days.
D. False: PML is a common complication of solid organ transplantation. In fact, PML is more common in immunocompromised patients, such as AIDS patients or those undergoing immunosuppressive therapy. Solid organ transplantation recipients are at risk due to the use of immunosuppressive medications, but the statement "common complication" is incorrect.

**Clinical Pearl:** It is crucial for medical professionals to recognize the clinical manifestations of PML in immunocompetent individuals, as this misconception might lead to misdiagnosis and inappropriate management. PML in immunocompetent individuals can present with atypical symptoms, such as cognitive decline, psychiatric symptoms, and focal neurological deficits, which can mimic other conditions like stroke, encephalitis, or brain tumors.